Opendata, web and dolomites

LPPDS

A portable peritoneal dialysis system for home use that monitors for infection

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LPPDS project word cloud

Explore the words cloud of the LPPDS project. It provides you a very rough idea of what is the project "LPPDS" about.

calculate    issue    patient    either    population    rate    longer    treatment    travelling    choosing    designed    reduce    kidneys    speeds    portable    plans    errors    market    decreasing    inhibit    kidney    adherence    prevalence    pending    liberdi    external    catheters    stage    lightweight    flow    obesity    offerings    day    patients    economic    decline    week    hypertension    peristaltic    efficacy    esrd    smart    fluid    human    exchange    correct    patent    doctors    health    times    consists    filtering    centres    disposable    haemodialysis    saving    truly    device    53    sufficiently    schedules    transplant    function    carry    chronic    ease    epidemics    minutes    public    compliance    hd    pd    last    time    sterile    poorer    seeing    latter    monitoring    share    diabetes    connectors    dialysis    peritoneal    occurs    caused    ckd    holds    automation    socio    session    takes    core    west    blood    hospitals    revolutionises    renal    eskd    complexity    difficult    hours    globally    adding    pump    home    recognised    fifth    aging    waste    end    protocol    doctor    travel    requiring    ux    lppds    disease   

Project "LPPDS" data sheet

The following table provides information about the project.

Coordinator
LIBERDI LTD 

Organization address
address: 17 T'CHELET STREET
city: MISGAV
postcode: 2017400
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website http://www.liberdi.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2018-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LIBERDI LTD IL (MISGAV) coordinator 50˙000.00

Map

 Project objective

End Stage Kidney Disease (ESKD) or End Stage Renal Disease (ESRD), the fifth and last stage of Chronic Kidney Disease (CKD), is recognised as a major public health problem. It occurs where kidneys are no longer capable of sufficiently filtering waste products from the blood. With kidney function at less than 10 %, a kidney transplant or an external means of filtering is needed. The latter consists of either Haemodialysis (HD) or Peritoneal Dialysis (PD). Globally, we are seeing an increasing prevalence in ESRD. This is caused by an aging population in the west, socio-economic factors, increasing hypertension, and growing diabetes and obesity epidemics.

The technical complexity of market offerings can inhibit many patients from choosing PD. HD takes an average of 4 hours per treatment session and occurs 3 times a week while PD occurs 4 times a day with each exchange requiring 40 minutes on average. Most dialysis occurs in specific dialysis centres and hospitals, adding further time for travel. Non-compliance with treatment schedules are a particular issue with PD. This makes it difficult for doctors to calculate correct treatment plans as patients may not share this information with their doctor. Non-compliance can be as high as 53%, decreasing efficacy of the treatment leading to poorer health overall and speeds up rate of decline.

liberDi revolutionises traditional Peritoneal Dialysis with LPPDS, a smart, real-time, patient-monitoring, truly portable device. It’s lightweight, easy to set up and allows patients carry out their dialysis at home, at work or while travelling. LPPDS has UX at the very core of its design to ensure ease of use: patent pending smart automation, catheters and sterile connectors. The system consists of a patent-pending disposable that holds a smart peristaltic pump designed to improve adherence to protocol, and reduce human errors, while saving time via fluid flow rate and management.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LPPDS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LPPDS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

RoboSynFarm (2019)

Robotic Synthesis Farm

Read More  

CAARESYS (2019)

CAARESYS: vehicle passenger monitoring system based on contactless low emission radio frequency radar.

Read More